Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 95-99

  Lee, Me Yeon ^a   Wu, Hong Gyun ^a   Kim, Kyubo ^a   Whan Ha, Sung ^a   Sung Kim, Jae ^a   Ah Kim, In ^a   Lee, Hyo Pyo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Carboplatin; Chemoradiation; Paclitaxel; Primary cervical cancer; Squamous cell cancer

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CYSTOVAGINAL FISTULA; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DYSURIA; EARLY CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INVASIVE CANDIDIASIS; LEUKOCYTE COUNT; LEUKOPENIA; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY FREQUENCY; UTERINE CERVIX CARCINOMA; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33846016968     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.07.021     Document Type: Article

References (27)

1. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N. Eng. J. Med. 340 (1999) 1137-1143
2. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky IB cervical carcinoma. N. Eng. J. Med. 340 (1999) 1154-1161
3. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N. Eng. J. Med. 340 (1999) 1144-1153
4. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 (1999) 1339-1348
5. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 (2000) 1606-1613
6. Pearcey R., Brundage R.P.M., Drouin P., et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J. Clin. Oncol. 20 (2002) 966-972
7. Monk B.J., Alberts D.S., Burger R.A., et al. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers. Gynecol. Oncol. 71 (1998) 308-312
8. Brock A., Prager W., Bohme R., et al. The methods and results of simultaneous radiochemotherapy with carboplatin in advanced cervical carcinoma. Strahlenther. Onkol. 170 (1994) 264-268
9. Gerson R., Tellez B., and Figueroa J. Phase II study of weekly carboplatin and simultaneous radiotherapy in advanced cervical cancer. Ann. Oncol. 5 Suppl. 8 (1994) 563 [Abstract]
10. Choi H.S., Byun J.S., and Chung W.K. Neoadjuvant chemotherapy combined carboplatin in high risk cervical cancer. Cancer Res. Treat. 26 (1994) 438-444
11. Kundelka A.P., Winn R., Edwards C.L., et al. An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anti-cancer Drugs 8 (1997) 657-661
12. McGuire W.P., Blessing J.A., Moore D., et al. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J. Clin. Oncol. 14 (1996) 792-795
13. Papadimitriou C.A., Sarris K., Moulopoulos L.A., et al. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J. Clin. Oncol. 17 (1999) 761-766
14. Moore D.H., Blessing J.A., McQuellon R.P., et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J. Clin. Oncol. 22 (2004) 3113-3119
15. Kim K., Chie E.K., Wu H.G., et al. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer. Gynecol. Oncol. 101 (2006) 398-402
16. de Vos F.Y.F.L., Bos A.M.E., Gietema J.A., et al. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer. Anticancer Res. 24 (2004) 345-348
17. Rao G.G., Rogers P., Drake R.D., et al. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecol. Oncol. 96 (2005) 168-172
18. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47 (2000) 13-47
19. Thigpen T., Vance R.T., and Kansur T. The platinum compounds and paclitaxel in the management of carcinoma of the endometrium and the uterine cervix. Semin. Oncol. 22 S12 (1995) 67-72
20. Micheletti E., Face B.L., Bianchi E., et al. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). Am. J. Clin. Oncol. 20 (1997) 613-620
21. Benjamin W.C., Bizhan M., Charles J.D., et al. Concomitant irradiation and dose-escalating carboplatin for locally advanced carcinoma of the uterine cervix: an updated report. Am. J. Clin. Oncol. 21 (1998) 31-35
22. Rein D.T., Kurbacher C.M., Breidenbach M., et al. Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer: a phase I study. Gynecol. Oncol. 87 (2002) 98-103
23. Duenas-Gonzalez A., Centina L., Sanchez B., et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 1361-1365
24. Higgins R.V., Naumann W.R., Hall J.B., et al. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of the cervix cancer. Gynecol. Oncol. 89 (2003) 499-503
25. Grigsby P.W., Heydon K., Mutch D.G., et al. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 51 (2001) 982-987
26. Varia M.A., Bundy B.N., Deppe G., et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 42 (2001) 1015-1023
27. Park C.I., Ha S.W., Kang S.B., et al. Radiotherapy result of the carcinoma of uterine cervix. J. Korean Soc. Ther. Radiol. Oncol. 2 (1984) 107-113